25 Dec 2011

Bid for review of Pharmac pricing turned down

9:59 am on 25 December 2011

The High Court has dismissed an application by a drug company for a review of pricing by Pharmac.

AstraZeneca challenged plans by the state drug-buying agency to reduce the subsidy on combination inhalers to match the subsidies in a deal it has with a competing company.

In a reserved decision, Justice Kos said he does not consider that Pharmac erred in law in the way in which it went about applying parity pricing in this case.